Company registration number 03476562 (England and Wales)
BALTIMORE CARE LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
BALTIMORE CARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
3 - 9
BALTIMORE CARE LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
352,462
349,422
Investments
5
1
1
352,463
349,423
Current assets
Stocks
-
500
Debtors
6
179,888
10,708
Cash at bank and in hand
325,248
94,031
505,136
105,239
Creditors: amounts falling due within one year
7
(313,172)
(100,443)
Net current assets
191,964
4,796
Total assets less current liabilities
544,427
354,219
Provisions for liabilities
(1,000)
(895)
Net assets
543,427
353,324
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves
542,427
352,324
Total equity
543,427
353,324

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 24 September 2025 and are signed on its behalf by:
Mr J George
Director
Company registration number 03476562 (England and Wales)
BALTIMORE CARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2023
1,000
556,265
557,265
Period ended 31 December 2023:
Profit and total comprehensive income
-
160,924
160,924
Dividends
-
(364,865)
(364,865)
Balance at 31 December 2023
1,000
352,324
353,324
Year ended 31 December 2024:
Profit and total comprehensive income
-
190,103
190,103
Balance at 31 December 2024
1,000
542,427
543,427
BALTIMORE CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
1
Accounting policies
Company information

Baltimore Care Limited is a private company limited by shares incorporated in England and Wales. The registered office is Baltimore House, 1 & 2 Park Road, Barry, CF62 6NU.

1.1
Reporting period

The current accounting period was shortened to 9 months, ending on 31 December 2023, in order to align it with the group financial year. The previous accounting period commenced on 1 April 2022 and ended on 31 March 2023.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Turnover

Turnover represents consideration received from the provision of care home and associated services. Revenue is recognised to the extent it is probable that the economic benefits will follow to the company and the revenue can be reliably measured.

 

Revenue is measured at the fair value of the consideration received or receivable, net of discounts.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold buildings
2% cost
Fixtures and fittings
15% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

BALTIMORE CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

BALTIMORE CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

BALTIMORE CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 6 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
40
42
BALTIMORE CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2024
621,625
87,266
708,891
Additions
16,509
-
0
16,509
At 31 December 2024
638,134
87,266
725,400
Depreciation and impairment
At 1 January 2024
276,911
82,558
359,469
Depreciation charged in the year
12,763
706
13,469
At 31 December 2024
289,674
83,264
372,938
Carrying amount
At 31 December 2024
348,460
4,002
352,462
At 31 December 2023
344,714
4,708
349,422
5
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
1
1
6
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
17,795
10,708
Amounts owed by group undertakings
118,963
-
0
Other debtors
43,130
-
0
179,888
10,708
BALTIMORE CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
7
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
38,615
148
Amounts owed to group undertakings
11,247
22,000
Corporation tax
126,442
56,069
Other taxation and social security
10,017
16,051
Other creditors
126,851
6,175
313,172
100,443
8
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Senior Statutory Auditor:
Indra Raj Giri ACA, FCCA
Statutory Auditor:
Makesworth Audit Services Limited
9
Related party transactions

During the year the Bellavista Care Centre Limited has charged £92,000 (2023: £22,000) as a service fee to the company. The fee was charged under normal commercial terms.

 

Included within debtors are amounts of £14.439 (2023: £nil) owed by Bellavista Care Centre Limited and £104,524 (2023: £nil) by The Waverley Care Centre Limited.

 

Included within creditors due within one year are the amounts of £11,247 (2023: £nil) owed to Middlepatch Limited and £nil (2023: £22,000) owed to Bellavista Care Centre Limited.

 

 

Bellavista Care Centre Limited is the company's parent company and The Waverley Care Centre Limited and Middlepatch Limited are fellow group companies.

10
Parent company

The company's parent company is Bellavista Care Centre Limited, a company registered in the UK. The consolidated financial statements of the group can be obtained from Companies House, Crown Way, Cardiff, CF14 3UZ.

 

On 8 December 2023, Bellavista Care Centre Limited acquired Baltimore Care Limited.

BALTIMORE CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
11
Charges

The freehold property at 1-2 Park Road, Barry CF62 6NU has been given as a first charge to Barclays Bank Plc towards the associated borrowing in respect of the acquisition of this business by the parent company Bellavista Care Centre Limited.

 

In addition, there are fixed and floating charges to Barclays Bank Plc against the properties or undertakings of the company.

2024-12-312024-01-01false24 September 2025CCH SoftwareCCH Accounts Production 2023.200No description of principal activityThis audit opinion is unqualifiedMr J GeorgeMrs B Jacob034765622024-01-012024-12-31034765622024-12-31034765622023-12-3103476562core:LandBuildings2024-12-3103476562core:OtherPropertyPlantEquipment2024-12-3103476562core:LandBuildings2023-12-3103476562core:OtherPropertyPlantEquipment2023-12-3103476562core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3103476562core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3103476562core:CurrentFinancialInstruments2024-12-3103476562core:CurrentFinancialInstruments2023-12-3103476562core:ShareCapital2024-12-3103476562core:ShareCapital2023-12-3103476562core:RetainedEarningsAccumulatedLosses2024-12-3103476562core:RetainedEarningsAccumulatedLosses2023-12-3103476562core:ShareCapital2023-03-3103476562core:RetainedEarningsAccumulatedLosses2023-03-3103476562bus:Director12024-01-012024-12-3103476562core:RetainedEarningsAccumulatedLosses2023-04-012023-12-31034765622023-04-012023-12-3103476562core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3103476562core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3103476562core:FurnitureFittings2024-01-012024-12-3103476562core:LandBuildings2023-12-3103476562core:OtherPropertyPlantEquipment2023-12-31034765622023-12-3103476562core:LandBuildings2024-01-012024-12-3103476562core:OtherPropertyPlantEquipment2024-01-012024-12-3103476562core:WithinOneYear2024-12-3103476562core:WithinOneYear2023-12-3103476562bus:PrivateLimitedCompanyLtd2024-01-012024-12-3103476562bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3103476562bus:FRS1022024-01-012024-12-3103476562bus:Audited2024-01-012024-12-3103476562bus:Director22024-01-012024-12-3103476562bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP